Literature DB >> 28369804

Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.

E Walton1,2,3, D P Hibar4, T G M van Erp5, S G Potkin5, R Roiz-Santiañez6,7, B Crespo-Facorro6,7, P Suarez-Pinilla6,7, N E M Van Haren8, S M C de Zwarte8, R S Kahn8, W Cahn8, N T Doan9, K N Jørgensen9,10, T P Gurholt9, I Agartz9,10,11, O A Andreassen9,12, L T Westlye12, I Melle9,12, A O Berg9,12, L Mørch-Johnsen9,10, A Faerden13, L Flyckt14, H Fatouros-Bergman14, E G Jönsson9,11, R Hashimoto15,16, H Yamamori16, M Fukunaga17, A Preda5, P De Rossi18,19,20, F Piras19,21, N Banaj19, V Ciullo19, G Spalletta19,20,22, R E Gur23, R C Gur23, D H Wolf23, T D Satterthwaite23, L M Beard23, I E Sommer8, S Koops8, O Gruber24, A Richter24, B Krämer24, S Kelly4,25, G Donohoe24, C McDonald26, D M Cannon26, A Corvin25, M Gill25, A Di Giorgio27, A Bertolino28, S Lawrie29, T Nickson29, H C Whalley29, E Neilson29, V D Calhoun30,31, P M Thompson4, J A Turner32, S Ehrlich2,33.   

Abstract

OBJECTIVE: Based on the role of the superior temporal gyrus (STG) in auditory processing, language comprehension and self-monitoring, this study aimed to investigate the relationship between STG cortical thickness and positive symptom severity in schizophrenia.
METHOD: This prospective meta-analysis includes data from 1987 individuals with schizophrenia collected at seventeen centres around the world that contribute to the ENIGMA Schizophrenia Working Group. STG thickness measures were extracted from T1-weighted brain scans using FreeSurfer. The study performed a meta-analysis of effect sizes across sites generated by a model predicting left or right STG thickness with a positive symptom severity score (harmonized SAPS or PANSS-positive scores), while controlling for age, sex and site. Secondary models investigated relationships between antipsychotic medication, duration of illness, overall illness severity, handedness and STG thickness.
RESULTS: Positive symptom severity was negatively related to STG thickness in both hemispheres (left: βstd = -0.052; P = 0.021; right: βstd = -0.073; P = 0.001) when statistically controlling for age, sex and site. This effect remained stable in models including duration of illness, antipsychotic medication or handedness.
CONCLUSION: Our findings further underline the important role of the STG in hallmark symptoms in schizophrenia. These findings can assist in advancing insight into symptom-relevant pathophysiological mechanisms in schizophrenia.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ENIGMA; FreeSurfer; MRI; cortical thickness; positive and negative syndrome scale; positive symptoms; scale for the assessment of positive symptoms; schizophrenia; superior temporal gyrus

Mesh:

Year:  2017        PMID: 28369804      PMCID: PMC5399182          DOI: 10.1111/acps.12718

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  40 in total

Review 1.  Predictors of long-term outcome in schizophrenia.

Authors:  Robin Emsley; Bonginkosi Chiliza; Renata Schoeman
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

Review 2.  Treatment-resistant schizophrenia.

Authors:  Helio Elkis
Journal:  Psychiatr Clin North Am       Date:  2007-09

Review 3.  Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena.

Authors:  Brent Elliott; Eileen Joyce; Simon Shorvon
Journal:  Epilepsy Res       Date:  2009-05-06       Impact factor: 3.045

4.  Structural alterations of the superior temporal gyrus in schizophrenia: Detailed subregional differences.

Authors:  K Ohi; Y Matsuda; T Shimada; T Yasuyama; K Oshima; K Sawai; H Kihara; Y Nitta; H Okubo; T Uehara; Y Kawasaki
Journal:  Eur Psychiatry       Date:  2016-04-07       Impact factor: 5.361

5.  Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum.

Authors:  Viola Oertel-Knöchel; Christian Knöchel; Anna Rotarska-Jagiela; Britta Reinke; David Prvulovic; Corinna Haenschel; Harald Hampel; David E J Linden
Journal:  Cereb Cortex       Date:  2012-01-30       Impact factor: 5.357

Review 6.  Predictors of schizophrenia--a review.

Authors:  Pirjo Mäki; Juha Veijola; Peter B Jones; Graham K Murray; Hannu Koponen; Pekka Tienari; Jouko Miettunen; Päivikki Tanskanen; Karl-Erik Wahlberg; Johanna Koskinen; Erika Lauronen; Matti Isohanni
Journal:  Br Med Bull       Date:  2005-06-09       Impact factor: 4.291

7.  Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features.

Authors:  B Crespo-Facorro; R Roiz-Santiáñez; R Pérez-Iglesias; J M Rodriguez-Sanchez; I Mata; D Tordesillas-Gutierrez; E Sanchez; R Tabarés-Seisdedos; N Andreasen; V Magnotta; J L Vázquez-Barquero
Journal:  Psychol Med       Date:  2010-10-14       Impact factor: 7.723

8.  Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability.

Authors:  Aaron L Goldman; Lukas Pezawas; Venkata S Mattay; Bruce Fischl; Beth A Verchinski; Qiang Chen; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Arch Gen Psychiatry       Date:  2009-05

9.  Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison.

Authors:  Emma Sprooten; Martina Papmeyer; Annya M Smyth; Daniel Vincenz; Sibylle Honold; Guy A Conlon; T William J Moorhead; Dominic Job; Heather C Whalley; Jeremy Hall; Andrew M McIntosh; David C G Owens; Eve C Johnstone; Stephen M Lawrie
Journal:  Schizophr Res       Date:  2013-10-10       Impact factor: 4.939

Review 10.  Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.

Authors:  Roberto Roiz-Santiañez; Paula Suarez-Pinilla; Benedicto Crespo-Facorro
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more
  24 in total

1.  Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.

Authors:  Dominik A Moser; Gaelle E Doucet; Won Hee Lee; Alexander Rasgon; Hannah Krinsky; Evan Leibu; Alex Ing; Gunter Schumann; Natalie Rasgon; Sophia Frangou
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

Review 2.  [Brain imaging in schizophrenia : A review of current trends and developments].

Authors:  Igor Nenadić
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

3.  Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models.

Authors:  Ana D Stan; Carol A Tamminga; Kihwan Han; Jong Bae Kim; Jaya Padmanabhan; Neeraj Tandon; Matthew E Hudgens-Haney; Matcheri S Keshavan; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

4.  Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.

Authors:  Eva Mennigen; Wenhao Jiang; Vince D Calhoun; Theo G M van Erp; Ingrid Agartz; Judith M Ford; Bryon A Mueller; Jingyu Liu; Jessica A Turner
Journal:  Schizophr Res       Date:  2019-02-26       Impact factor: 4.939

5.  Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?

Authors:  Theo G M van Erp; Esther Walton; Derrek P Hibar; Lianne Schmaal; Wenhao Jiang; David C Glahn; Godfrey D Pearlson; Nailin Yao; Masaki Fukunaga; Ryota Hashimoto; Naohiro Okada; Hidenaga Yamamori; Vincent P Clark; Bryon A Mueller; Sonja M C de Zwarte; Roel A Ophoff; Neeltje E M van Haren; Ole A Andreassen; Tiril P Gurholt; Oliver Gruber; Bernd Kraemer; Anja Richter; Vince D Calhoun; Benedicto Crespo-Facorro; Roberto Roiz-Santiañez; Diana Tordesillas-Gutiérrez; Carmel Loughland; Stanley Catts; Janice M Fullerton; Melissa J Green; Frans Henskens; Assen Jablensky; Bryan J Mowry; Christos Pantelis; Yann Quidé; Ulrich Schall; Rodney J Scott; Murray J Cairns; Marc Seal; Paul A Tooney; Paul E Rasser; Gavin Cooper; Cynthia Shannon Weickert; Thomas W Weickert; Elliot Hong; Peter Kochunov; Raquel E Gur; Ruben C Gur; Judith M Ford; Fabio Macciardi; Daniel H Mathalon; Steven G Potkin; Adrian Preda; Fengmei Fan; Stefan Ehrlich; Margaret D King; Lieuwe De Haan; Dick J Veltman; Francesca Assogna; Nerisa Banaj; Pietro de Rossi; Mariangela Iorio; Fabrizio Piras; Gianfranco Spalletta; Edith Pomarol-Clotet; Sinead Kelly; Simone Ciufolini; Joaquim Radua; Robin Murray; Tiago Reis Marques; Andrew Simmons; Stefan Borgwardt; Fabienne Schönborn-Harrisberger; Anita Riecher-Rössler; Renata Smieskova; Kathryn I Alpert; Alessandro Bertolino; Aurora Bonvino; Annabella Di Giorgio; Emma Neilson; Andrew R Mayer; Je-Yeon Yun; Dara M Cannon; Irina Lebedeva; Alexander S Tomyshev; Tolibjohn Akhadov; Vasily Kaleda; Helena Fatouros-Bergman; Lena Flyckt; Pedro G P Rosa; Mauricio H Serpa; Marcus V Zanetti; Cyril Hoschl; Antonin Skoch; Filip Spaniel; David Tomecek; Andrew M McIntosh; Heather C Whalley; Christian Knöchel; Viola Oertel-Knöchel; Fleur M Howells; Dan J Stein; Henk S Temmingh; Anne Uhlmann; Carlos Lopez-Jaramillo; Danai Dima; Joshua I Faskowitz; Boris A Gutman; Neda Jahanshad; Paul M Thompson; Jessica A Turner
Journal:  Biol Psychiatry       Date:  2018-11-22       Impact factor: 13.382

Review 6.  Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings.

Authors:  Eun-Jin Cheon; Carrie E Bearden; Daqiang Sun; Christopher R K Ching; Ole A Andreassen; Lianne Schmaal; Dick J Veltman; Sophia I Thomopoulos; Peter Kochunov; Neda Jahanshad; Paul M Thompson; Jessica A Turner; Theo G M van Erp
Journal:  Psychiatry Clin Neurosci       Date:  2022-02-26       Impact factor: 12.145

7.  Individual-specific functional connectivity markers track dimensional and categorical features of psychotic illness.

Authors:  Danhong Wang; Meiling Li; Meiyun Wang; Justin T Baker; Hesheng Liu; Franziska Schoeppe; Jianxun Ren; Huafu Chen; Dost Öngür; Roscoe O Brady
Journal:  Mol Psychiatry       Date:  2018-11-15       Impact factor: 15.992

8.  Using deep autoencoders to identify abnormal brain structural patterns in neuropsychiatric disorders: A large-scale multi-sample study.

Authors:  Walter H L Pinaya; Andrea Mechelli; João R Sato
Journal:  Hum Brain Mapp       Date:  2018-10-11       Impact factor: 5.038

9.  Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex.

Authors:  Atsumi Nitta; Naotaka Izuo; Kohei Hamatani; Ryo Inagaki; Yuka Kusui; Kequan Fu; Takashi Asano; Youta Torii; Chikako Habuchi; Hirotaka Sekiguchi; Shuji Iritani; Shin-Ichi Muramatsu; Norio Ozaki; Yoshiaki Miyamoto
Journal:  J Pers Med       Date:  2021-06-26

10.  Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

Authors:  Theo G M van Erp; Esther Walton; Derrek P Hibar; Lianne Schmaal; Wenhao Jiang; David C Glahn; Godfrey D Pearlson; Nailin Yao; Masaki Fukunaga; Ryota Hashimoto; Naohiro Okada; Hidenaga Yamamori; Juan R Bustillo; Vincent P Clark; Ingrid Agartz; Bryon A Mueller; Wiepke Cahn; Sonja M C de Zwarte; Hilleke E Hulshoff Pol; René S Kahn; Roel A Ophoff; Neeltje E M van Haren; Ole A Andreassen; Anders M Dale; Nhat Trung Doan; Tiril P Gurholt; Cecilie B Hartberg; Unn K Haukvik; Kjetil N Jørgensen; Trine V Lagerberg; Ingrid Melle; Lars T Westlye; Oliver Gruber; Bernd Kraemer; Anja Richter; David Zilles; Vince D Calhoun; Benedicto Crespo-Facorro; Roberto Roiz-Santiañez; Diana Tordesillas-Gutiérrez; Carmel Loughland; Vaughan J Carr; Stanley Catts; Vanessa L Cropley; Janice M Fullerton; Melissa J Green; Frans A Henskens; Assen Jablensky; Rhoshel K Lenroot; Bryan J Mowry; Patricia T Michie; Christos Pantelis; Yann Quidé; Ulrich Schall; Rodney J Scott; Murray J Cairns; Marc Seal; Paul A Tooney; Paul E Rasser; Gavin Cooper; Cynthia Shannon Weickert; Thomas W Weickert; Derek W Morris; Elliot Hong; Peter Kochunov; Lauren M Beard; Raquel E Gur; Ruben C Gur; Theodore D Satterthwaite; Daniel H Wolf; Aysenil Belger; Gregory G Brown; Judith M Ford; Fabio Macciardi; Daniel H Mathalon; Daniel S O'Leary; Steven G Potkin; Adrian Preda; James Voyvodic; Kelvin O Lim; Sarah McEwen; Fude Yang; Yunlong Tan; Shuping Tan; Zhiren Wang; Fengmei Fan; Jingxu Chen; Hong Xiang; Shiyou Tang; Hua Guo; Ping Wan; Dong Wei; Henry J Bockholt; Stefan Ehrlich; Rick P F Wolthusen; Margaret D King; Jody M Shoemaker; Scott R Sponheim; Lieuwe De Haan; Laura Koenders; Marise W Machielsen; Therese van Amelsvoort; Dick J Veltman; Francesca Assogna; Nerisa Banaj; Pietro de Rossi; Mariangela Iorio; Fabrizio Piras; Gianfranco Spalletta; Peter J McKenna; Edith Pomarol-Clotet; Raymond Salvador; Aiden Corvin; Gary Donohoe; Sinead Kelly; Christopher D Whelan; Erin W Dickie; David Rotenberg; Aristotle N Voineskos; Simone Ciufolini; Joaquim Radua; Paola Dazzan; Robin Murray; Tiago Reis Marques; Andrew Simmons; Stefan Borgwardt; Laura Egloff; Fabienne Harrisberger; Anita Riecher-Rössler; Renata Smieskova; Kathryn I Alpert; Lei Wang; Erik G Jönsson; Sanne Koops; Iris E C Sommer; Alessandro Bertolino; Aurora Bonvino; Annabella Di Giorgio; Emma Neilson; Andrew R Mayer; Julia M Stephen; Jun Soo Kwon; Je-Yeon Yun; Dara M Cannon; Colm McDonald; Irina Lebedeva; Alexander S Tomyshev; Tolibjohn Akhadov; Vasily Kaleda; Helena Fatouros-Bergman; Lena Flyckt; Geraldo F Busatto; Pedro G P Rosa; Mauricio H Serpa; Marcus V Zanetti; Cyril Hoschl; Antonin Skoch; Filip Spaniel; David Tomecek; Saskia P Hagenaars; Andrew M McIntosh; Heather C Whalley; Stephen M Lawrie; Christian Knöchel; Viola Oertel-Knöchel; Michael Stäblein; Fleur M Howells; Dan J Stein; Henk S Temmingh; Anne Uhlmann; Carlos Lopez-Jaramillo; Danai Dima; Agnes McMahon; Joshua I Faskowitz; Boris A Gutman; Neda Jahanshad; Paul M Thompson; Jessica A Turner
Journal:  Biol Psychiatry       Date:  2018-05-14       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.